{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:41:56Z","timestamp":1776692516384,"version":"3.51.2"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1124\/jpet.118.254219","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T20:01:53Z","timestamp":1556308913000},"page":"9-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome"],"prefix":"10.1016","volume":"370","author":[{"given":"Bryce A.","family":"Griffin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin O.","family":"Caperton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren N.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian V.","family":"Cabanlong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catheryn D.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle R.","family":"Urquhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford S.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelle Dina","family":"Zita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L.","family":"Patton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander W.","family":"Alund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Michael","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Fantegrossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery H.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa K.","family":"Brents","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.254219_bib1","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1097\/CCM.0b013e318265680a","article-title":"Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice","volume":"40","author":"Alhaddad","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.118.254219_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0091-3057(97)00596-0","article-title":"Neonatal withdrawal following pre- and postnatal exposure to methadone in the rat","volume":"60","author":"Barr","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.118.254219_bib3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1479-828X.2012.01424.x","article-title":"Buprenorphine exposure in infants of opioid-dependent mothers at birth","volume":"52","author":"Bartu","year":"2012","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1124\/jpet.118.254219_bib4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/aje\/kwu190","article-title":"Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis","volume":"180","author":"Brogly","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1124\/jpet.118.254219_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.112.193433","article-title":"P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception","volume":"343","author":"Brown","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.254219_bib6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/dmd.105.006148","article-title":"Novel metabolites of buprenorphine detected in human liver microsomes and human urine","volume":"34","author":"Chang","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.118.254219_bib7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1542\/hpeds.2016-0218","article-title":"Male sex associated with increased risk of neonatal abstinence syndrome","volume":"7","author":"Charles","year":"2017","journal-title":"Hosp Pediatr"},{"key":"10.1124\/jpet.118.254219_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/FTD.0b013e318228bb2a","article-title":"Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women","volume":"33","author":"Concheiro","year":"2011","journal-title":"Ther Drug Monit"},{"key":"10.1124\/jpet.118.254219_bib9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jat\/34.8.498","article-title":"Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes","volume":"34","author":"Concheiro","year":"2010","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.118.254219_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0928-0987(02)00009-X","article-title":"Characterization of the pharmacokinetics of buprenorphine and norbuprenorphine in rats after intravenous bolus administration of buprenorphine","volume":"15","author":"Gopal","year":"2002","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/jpet.118.254219_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.bcp.2009.10.026","article-title":"Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms","volume":"79","author":"Hemauer","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.118.254219_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugalcdep.2010.05.015","article-title":"Gender and NAS: does sex matter?","volume":"112","author":"Holbrook","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.118.254219_bib13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3565(24)29586-0","article-title":"Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist","volume":"297","author":"Huang","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.254219_bib14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.drugalcdep.2010.01.004","article-title":"Infant autonomic functioning and neonatal abstinence syndrome","volume":"109","author":"Jansson","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.118.254219_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/14767050701490327","article-title":"Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates","volume":"20","author":"Jansson","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1124\/jpet.118.254219_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5055\/jom.2009.0006","article-title":"The opioid-exposed newborn: assessment and pharmacologic management","volume":"5","author":"Jansson","year":"2009","journal-title":"J Opioid Manag"},{"key":"10.1124\/jpet.118.254219_bib17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.drugalcdep.2013.11.006","article-title":"Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy","volume":"134","author":"Jones","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.118.254219_bib18","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.118.254219_bib19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0091-3057(00)00209-4","article-title":"Opiate withdrawal in the fetal rat: a behavioral profile","volume":"66","author":"Jones","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.118.254219_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fgene.2013.00012","article-title":"Pharmacogenomics of cytochrome P450 3A4: recent progress toward the \u201cmissing heritability\u201d problem","volume":"4","author":"Klein","year":"2013","journal-title":"Front Genet"},{"key":"10.1124\/jpet.118.254219_bib21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1515\/jpm-2012-0288","article-title":"Are there gender related differences in neonatal abstinence syndrome following exposure to buprenorphine during pregnancy?","volume":"41","author":"O\u2019Connor","year":"2013","journal-title":"J Perinat Med"},{"key":"10.1124\/jpet.118.254219_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000441220","article-title":"Maternal buprenorphine dose at delivery and its relationship to neonatal outcomes","volume":"22","author":"O\u2019Connor","year":"2016","journal-title":"Eur Addict Res"},{"key":"10.1124\/jpet.118.254219_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0090-9556(25)08299-6","article-title":"Pharmacokinetic analysis of enterohepatic circulation of buprenorphine and its active metabolite, norbuprenorphine, in rats","volume":"22","author":"Ohtani","year":"1994","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.118.254219_bib24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/jp.2015.36","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012 [published correction appears in J Perinatol (2015) 35:667]","volume":"35","author":"Patrick","year":"2015","journal-title":"J Perinatol"},{"key":"10.1124\/jpet.118.254219_bib25","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"key":"10.1124\/jpet.118.254219_bib26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1124\/dmd.105.003681","article-title":"In vitro metabolism study of buprenorphine: evidence for new metabolic pathways","volume":"33","author":"Picard","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.118.254219_bib27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1476-5381.2010.00709.x","article-title":"Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety","volume":"160","author":"Samer","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.118.254219_bib28","series-title":"Drug Therapy in Pregnancy","first-page":"5","article-title":"Pharmacokinetics of drugs during pregnancy and lactation","author":"Schoonover","year":"2001"},{"key":"10.1124\/jpet.118.254219_bib29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1186\/s40064-016-2576-8","article-title":"Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?","volume":"5","author":"Shah","year":"2016","journal-title":"Springerplus"},{"key":"10.1124\/jpet.118.254219_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.genm.2011.10.001","article-title":"Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates?","volume":"8","author":"Unger","year":"2011","journal-title":"Gend Med"},{"key":"10.1124\/jpet.118.254219_bib31","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1124\/jpet.106.115972","article-title":"Pharmacokinetic-pharmacodynamic modeling of the respiratory depressant effect of norbuprenorphine in rats","volume":"321","author":"Yassen","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.254219_bib32","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/add.13462","article-title":"Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child","volume":"111","author":"Zedler","year":"2016","journal-title":"Addiction"},{"key":"10.1124\/jpet.118.254219_bib33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijdevneu.2004.06.005","article-title":"The role of AMPA and metabotropic glutamate receptors on morphine withdrawal in infant rats","volume":"22","author":"Zhu","year":"2004","journal-title":"Int J Dev Neurosci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524259073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524259073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.254219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T15:57:37Z","timestamp":1739980657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524259073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0022356524259073"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.254219","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.254219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}